Align Technology (ALGN) said on Tuesday morning its board has authorized the repurchase of up to $1 billion of the medical device company's common shares over the next three years.
The dental technology company completed its most recent stock buyback program in May 2025, or roughly 28 months after the prior $1 billion buyback program began in January 2023.
Price: 176.12, Change: -1.49, Percent Change: -0.84
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.